Advanced Enzyme Technologies (NSE)
曾用名： Advanced Biochemicals Limited
Advanced Enzyme Technologies Limited 是一家研发驱动的公司，在酶和益生菌生产领域居全球前列，面向制药、保健食品、动物保健、烘焙、农业、废弃物管理、纺织、皮革、蒸馏、粮食加工、酿造、果汁加工等众多行业提供环保安全的解决方案，酶和益生菌制剂替代医疗与工业用途的烈性药物和化学品。
简介
Advanced Enzyme Technologies Limited (AETL; NSE: ADVENZYMES, BSE: 540025) is a research-driven specialty biotech company that R&D, manufactures, and markets enzymes and probiotics used across human nutrition, animal nutrition, baking, and bio-processing industries, aiming to replace chemical processes with eco-safe enzymatic solutions. Incorporated in 1989; registered office in Thane, Maharashtra, India (corporate office also in Thane). Core products: enzymes and probiotics (100% of turnover in FY25-26). Technology: microbial fermentation with ~500 m3 fermentation capacity; 15+ patents; developed/upscaled probiotic production technologies. Scale: FY26 standalone turnover ₹4,527.66m; employees ~400 (as of FY25-26 end); exports are 33.58% of revenues; PAN-India presence and exports to 52 countries; 4 plants, 2 offices in India; 2 R&D labs; ~500+ employees/750+ employees figures also cited in materials. Ownership/listing/investors: listed on BSE and NSE since Aug 2016; shareholders include public and notable funds like Nalanda India Equity Fund, Orbimed Asia, Cl arus Capital, Marval Capital, Polunin Capital (examples shown). Funding: no specific 2025-26 funding disclosed in results; historical note mentions Kotak Private Equity investment and equity/IPO-related milestones, but not new funding for 2025-26. Key customers/partners: sells proprietary enzymes & probiotics and customized solutions to human nutrition, animal nutrition, and bio-processing industry customers; 700+ customers worldwide and >400 proprietary products; customers across 45+ countries. Latest 2025-26 developments and active status: FY2025-26 BRSR and FY26 earnings/annual reporting were published, with consolidated revenue from operations ₹7,458m (FY26), and the company remains active in 2025-26 reporting. In FY25-26 it also approved and incorporated a new subsidiary, Advanced Nutrazyme Private Limited (incorporated 4 July 2025).
Sources#
供应的生物解决方案 3
| D1E– | 以焙烤用酶（真菌淀粉酶、麦芽糖淀粉酶、木聚糖酶、葡萄糖氧化酶、脂肪酶）加抗坏血酸替代溴酸钾和偶氮甲酰胺作面粉处理剂 |
| D1E– | 以酶和生物脱毒管理霉菌毒素风险，而不只靠黏土吸附剂 |
| D3E2 | 纺织湿加工用酶——生物精练（果胶酶）、酶法退浆（淀粉酶）、纤维素酶“生物石磨”和漆酶牛仔漂白、过氧化氢酶去除双氧水——替代烧碱精练、浮石水洗、高锰酸钾喷洒和次氯酸盐漂白 |
已核实的产品关联: bioscouring → T02; Laccase and peroxidase → T02, T03; Cool type amylases → T02; replace chemicals or processes that present safety → I07, I02;
产品与服务
认证: ISO 22000:2005; ISO 9001:2008; WHO cGMP; ISO 9001:2015; Indonesian Halal; SSS Europe; FSSC 22000; GMP; Star Export House; ISO Certified Company
生产与研发基地 10
- India Enzymes and Probiotics
- U.S. Enzymes and Probiotics
- Europe Enzymes and Probiotics
- Pitampur SEZ, District Dhar, Madhya Pradesh, India
- Sinnar, District Nashik, Maharashtra, India
- Vashind, District Thane, Maharashtra
- Vashind, District Thane, Maharashtra, India
- Satpur, District Nashik, Maharashtra, India
- Chino, California, United States
- India
来自公司网站及自动化调研的生产、研发等基地；不含街道地址。
- 认证（官网）
- ISO 22000:2005 · ISO 9001:2008 · WHO cGMP · ISO 9001:2015 · Indonesian Halal · SSS Europe · FSSC 22000 · GMP · Star Export House · ISO Certified Company · GMP Plus · IRQS
- 客户与合作伙伴
- 700 customers across 45 countries worldwide · three wholly owned subsidiaries · three joint ventures · five stepdown subsidiaries · over 40 Countries · Evoxx Technologies GmbH
- 研发设施
- Process Development Lab · Applied Microbiology Lab · Life Sciences Application Lab · Food Applications Development Lab · Industrial Applications Development Lab
摘自公司官网: about · products · production · quality · rnd · leadership · contact · topic
子公司: Advanced Bio-Agro Tech Limited · Enzytech Advanced Solutions Limited · Enzymes Advanced (‘AEU’) USA, Inc. · Advanced Supplementary Technologies Corporation · Cal India International Foods (CAL) · Enzyme Innovation, Inc · Starya Labs, Inc. · JC Biotech Private Limited · Scitech Specialities Private Limited · Advanced Enzymes Europe B.V. (AEEBV) · Evoxx Technologies GmbH · Saiganesh Enzytech Solutions Private Limited
商业模式 · enzymes
Advanced Enzyme Technologies Ltd is a research-driven company that manufactures and markets a wide range of enzymes and probiotics for industries including human nutrition, animal nutrition, and bio-processing. It provides proprietary products and customized solutions to over 700 clients across more than 45 countries. The company earns revenue through the sale of these performance ingredients, often pricing based on the value created for customers through its specialized technical know-how and R&D capabilities.
| Enzymes and Probiotics FY26 The company's consolidated revenue for FY26 was 7,458 million INR, with a consolidated EBITDA margin of 31%. “Revenue from operations rose 17% to ₹7,458 million from ₹6,369 million in FY25... EBITDA (excl. other income): ₹2,291 million (31%)” | scanx.trade weak (company, news, market research, other) |
| FY26 Consolidated R&D expenditure for FY26 was 246 million INR, representing 3.30% of net sales. “Consolidated R&D expenditure for FY26 was ₹246 million (3.30% of net sales), compared to ₹248 million (3.86% of net sales) in FY25.” | scanx.trade weak (company, news, market research, other) |
| 1989 Advanced Enzyme was incorporated in 1989 by Mr V L Rathi and Mr C L Rathi as Advanced Biochemicals Pvt Ltd and was renamed in 2005. “Advanced Enzyme was incorporated in 1989 by Mr V L Rathi and Mr C L Rathi as Advanced Biochemicals Pvt Ltd; it was renamed in 2005.” | www.crisil.com weak (company, news, market research, other) |
The company operates in a highly volatile industry where R&D risks include cost escalation due to elongated timelines and potential lower ROI from delayed product launches. “Risk The Company operates in highly volatile & evolving industry that needs continuos and efficient R&D. Many a times R&D takes more than expected time & resources, leading to the cost escalation. At times, despite …” | www.advancedenzymes.com weak (company, news, market research, other) |
| Enzymes and probiotics Enzymes can often replace chemicals or processes that present safety or environmental issues. “Developed Enzymes and probiotics. Enzymes can often replace chemicals or processes that present safety or environmental issues.” | www.advancedenzymes.com weak (company, news, market research, other) |
| ADDSCOUR (Alkaline pectinase) The use of alkaline pectinase for bioscouring of cotton reduces environmental impact and is often more economical than conventional chemical scouring. “The use of an alkaline pectinase reduces the environmental impact, and in most cases, works out to be more economical.” | advancedenzymes.com weak (company, news, market research, other) |
| Alkaline pectinase (Biopreparation process) Biopreparation using alkaline pectinase allows for a reduction in rinsing water by more than half compared to traditional processes, saving significant energy. “It has been welcomed because rinsing water can be reduced by more than half compared to the traditional processes.” | advancedenzymes.com weak (company, news, market research, other) |
| Laccase and peroxidase (e.g., INDIGO WASH, INDIGO WASH Laccase) Laccase and peroxidase enzymes are used to create an aged look on denim while replacing bleaching chemicals. “Laccase and different types of peroxidase helped meet this giving a novel finish to need, being very effective for denim while replacing bleaching chemicals.” | advancedenzymes.com weak (company, news, market research, other) |
| COOL TYPE AMYLASES and COOL TYPE CELLULASES (e.g., RAPIDENZ COOL) Cool type amylases and cellulases enable a completely cool process for denim garment processing, which saves energy. “For denim garment processing, Advanced Enzymes offers a completely cool process. This is achieved with COOL TYPE AMYLASES and COOL TYPE CELLULASES.” | advancedenzymes.com weak (company, news, market research, other) |
状态
近期新闻 5
由自动检索获得；摘要为机器生成的英文。标题含公司名称，或摘要以该公司为主体——引用前请核对原文。
- 2026-09-21 Advanced Enzyme Tech buys 50,000 shares on Sep 21 at avg ₹289.49 scanx.tradeAdvanced Enzyme Technologies is steadily progressing with its open market buyback, having purchased 50,000 shares at an average ₹289.49 on Sep 21, 2026, bringing total bought-back to 14,58,904 shares, well within its defined buyback size and timetable. The company emphasizes …
- 2026-09-08 Advanced Enzyme Technologies extinguishes 8.25 lakh shares bought back scanx.tradeAdvanced Enzyme Technologies extinguished 8,25,028 equity shares bought back in August 2026 via open market, processed by CDSL on Sep 2, 2026, in dematerialized form, under SEBI Buy-Back Regulations 2018. The company also reported a Q1FY27 PAT decline to ₹386 million, announced a …
- 2026-08-20 Advanced Enzyme Consolidated June 2026 Net Sales at Rs 189.79 crore, up 2.08% Y-o-Y- Moneycontrol.com moneycontrol.comAdvanced Enzyme Technologies posted June 2026 consolidated net sales of Rs 189.79 crore, up 2.08% year-on-year, but net profit declined to Rs 37.09 crore (down 7.1% YoY) and EPS fell to Rs 3.31. Revenue was lower than the previous quarter’s Rs 203.37 crore, with modest declines …
- 2026-08-08 Advanced Enzymes Q1 results: Profit, EBITDA slips, company announces share buyback - CNBC TV18 cnbctv18.comAdvanced Enzyme Technologies posted a Q1 FY27 profit of ₹37 crore (down 7.5% YoY) with revenue up 2.2% to ₹190 crore and EBITDA down 9.6% to ₹51.1 crore, margins sliding to 26.9%. The board approved a buyback of up to ₹697 million at a maximum ₹500 per share and an acquisition to …
- 2026-08-08 Advanced Enzyme Technologies consolidated net profit declines 7.11% in the June 2026 quarter| Capital Market News capitalmarket.comAdvanced Enzyme Technologies’ June 2026 quarter shows a decline in net profit by 7.11% to Rs 37.09 crore, despite sales rising 2.09% to Rs 189.79 crore. Operating margin decreased (OPM from 30.35% to 26.86%), with both PBDT and PBT dipping slightly.
关系网络：股东、合作伙伴、同类
股权与投资方 13
| 子公司 | Advanced Bio-Agro Tech Limited |
| 子公司 | Enzytech Advanced Solutions Limited |
| 子公司 | Enzymes Advanced |
| 子公司 | Advanced Supplementary Technologies Corporation |
| 子公司 | Cal India International Foods |
| 子公司 | Enzyme Innovation, Inc |
| 子公司 | Starya Labs, Inc |
| 子公司 | JC Biotech Private Limited |
| 子公司 | Scitech Specialities Private Limited |
| 子公司 | Advanced Enzymes Europe B.V |
| 子公司 | Evoxx Technologies GmbH |
| 子公司 | Saiganesh Enzytech Solutions Private Limited |
| 子公司 | Advanced Nutrazyme Private Limited |
合作与交易 2
| 交易对手 | JC Biotech Private Limited (acquired remaining 4.28% stake) …The company initiated an open market buyback of its equity shares in August 2026 and completed the acquisition of the remaining stake in its subsidiary, JC Biotech, in 2026.… |
| 合资企业 | Evoxx Technologies GmbH ( …customers across 45 countries worldwide ( )
- three wholly owned subsidiaries ( )
- three joint ventures ( )
- five stepdown subsidiaries ( )
- over 40 Countries ( )
- Evoxx Technologies GmbH (… |
同类企业
S.I. Biozyme · Amano Enzyme · Qingdao Vland Biotech Group Co., Ltd. · KDN Biotech (SHANGHAI) CO., LTD · Sanzyme Biologics · Sunson Industry Group Co., Ltd · XIKE Enzymes · Enzyme Bioscience Pvt Ltd
公司信息
注册编号
- CIN: L24200MH1989PLC051018
- ISIN: INE837H01020
- PAN: AABCA4555E
融资
- 最近一轮: Post ipo equity · 2022-09-20 · US$ 9.9 M
- 累计融资: US$ 44.2 M
来自自动化调研（公司网站、公告、商业企业数据库），未经人工核对。注册编号请以官方登记为准。
身份与联系方式
联系方式、人员和法律信息仅向会员开放。
会员登录